(Total Views: 720)
Posted On: 05/26/2024 6:25:07 PM
Post# of 154115
sean007 -- that $10b could easily be leveraged to $100b plus, on really good LL readouts, from a couple different indications, etc.., validating CCR5 & patents.
Just using rounded off 10x's, as a quick napkin math.
Down the distant, twisted road, Cytodyn could command a staggering buyout --- even @ today's S/O.
Easily $75 -$100.
Especially when broken down over say 15-20+ yrs.(?)
Although I don't prefer one myself.
Just brainstorming on that $10b comment.
We now really have the easy side of the workload:
Watching LL get cut loose to perform & validate.
: )
Shall see....
Just using rounded off 10x's, as a quick napkin math.
Down the distant, twisted road, Cytodyn could command a staggering buyout --- even @ today's S/O.
Easily $75 -$100.
Especially when broken down over say 15-20+ yrs.(?)
Although I don't prefer one myself.
Just brainstorming on that $10b comment.
We now really have the easy side of the workload:
Watching LL get cut loose to perform & validate.
: )
Shall see....
(3)
(0)
